272 related articles for article (PubMed ID: 34236345)
1. Emerging role for local therapy in oligometastatic prostate cancer.
Khondakar NR; Owens-Walton J; Daneshvar M; Williams C; O'Connor L; Yerram NK; Pinto PA
Clin Adv Hematol Oncol; 2021 Jul; 19(7):460-467. PubMed ID: 34236345
[TBL] [Abstract][Full Text] [Related]
2. Local Therapeutics for the Treatment of Oligo Metastatic Prostate Cancer.
Jalfon MJ; Sakhalkar OV; Lokeshwar SD; Marks VA; Choksi AU; Klaassen Z; Leapman MS; Kim IY
Curr Urol Rep; 2023 Oct; 24(10):455-461. PubMed ID: 37369828
[TBL] [Abstract][Full Text] [Related]
3. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
Slaoui A; Albisinni S; Aoun F; Assenmacher G; Al Hajj Obeid W; Diamand R; Regragui S; Touzani A; Bakar A; Mesfioui A; Karmouni T; Ameur A; Elkhader K; Koutani A; Ibnattya A; Roumeguere T; Peltier A
World J Urol; 2019 Nov; 37(11):2343-2353. PubMed ID: 30706122
[TBL] [Abstract][Full Text] [Related]
5. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
Ranasinghe W; Chapin BF; Kim IY; Sooriakumaran P; Lawrentschuk N
BJU Int; 2020 Jun; 125(6):792-800. PubMed ID: 32176456
[TBL] [Abstract][Full Text] [Related]
6. The cytoreductive radical prostatectomy in metastatic prostate cancer.
Vladimír Š; Zuzana S; Hana Š
Klin Onkol; 2022; 35(1):55-62. PubMed ID: 35236082
[TBL] [Abstract][Full Text] [Related]
7. Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm.
Weiner AB; Nettey OS; Morgans AK
Curr Treat Options Oncol; 2019 Jul; 20(9):69. PubMed ID: 31286275
[TBL] [Abstract][Full Text] [Related]
8. The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.
Kim J; Park JS; Ham WS
Investig Clin Urol; 2017 Sep; 58(5):307-316. PubMed ID: 28868501
[TBL] [Abstract][Full Text] [Related]
9. Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer.
Deek MP; Tran PT
Cancer J; 2020; 26(2):137-143. PubMed ID: 32205538
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Approaches Prior To Radical Prostatectomy.
Ryan ST; Patel DN; Parsons JK; McKay RR
Cancer J; 2020; 26(1):2-12. PubMed ID: 31977379
[TBL] [Abstract][Full Text] [Related]
11. Local treatment for metastatic prostate cancer: A systematic review.
Tilki D; Pompe RS; Bandini M; Marchioni M; Kretschmer A; Tian Z; Karakiewicz PI; Evans CP
Int J Urol; 2018 May; 25(5):390-403. PubMed ID: 29572963
[TBL] [Abstract][Full Text] [Related]
12. The oncologic role of local treatment in primary metastatic prostate cancer.
Ghadjar P; Briganti A; De Visschere PJ; Fütterer JJ; Giannarini G; Isbarn H; Ost P; Sooriakumaran P; Surcel CI; van den Bergh RC; van Oort IM; Yossepowitch O; Ploussard G
World J Urol; 2015 Jun; 33(6):755-61. PubMed ID: 24997127
[TBL] [Abstract][Full Text] [Related]
13. [Treatment concepts for primary oligometastatic prostate cancer].
Knipper S; Graefen M; Hadaschik B; Wiegel T
Urologe A; 2020 Jun; 59(6):659-664. PubMed ID: 32274541
[TBL] [Abstract][Full Text] [Related]
14. [Surgical treatment of local disease in metastatic prostate cancer.].
Gaya JM; Huguet J; Breda A; Palou J
Arch Esp Urol; 2018 Mar; 71(3):288-297. PubMed ID: 29633950
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Role of Local Therapy in Metastatic Prostate Cancer.
Sundahl N; Tree A; Parker C
Curr Oncol Rep; 2020 Jan; 22(1):2. PubMed ID: 31960153
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?
Cahill EM; Pfail JL; Fu MZ; Saraiya B; Mayer T; Stephenson RD; Ennis RD; Hathout L; Deek MP; Ghodoussipour S; Jang TL
Curr Urol Rep; 2023 Jul; 24(7):299-306. PubMed ID: 37017928
[TBL] [Abstract][Full Text] [Related]
17. Current evidence on local therapy in oligometastatic prostate cancer.
Basourakos SP; Henning G; Karnes RJ
Curr Opin Urol; 2024 May; 34(3):198-203. PubMed ID: 38305293
[TBL] [Abstract][Full Text] [Related]
18. Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?
Canby-Hagino ED; Swanson GP; Crawford ED; Basler JW; Hernandez J; Thompson IM
Curr Urol Rep; 2005 May; 6(3):183-9. PubMed ID: 15869722
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy.
Ravi P; Karnes RJ; Rangel LJ; Pagliaro LC
J Urol; 2018 Nov; 200(5):1075-1081. PubMed ID: 29709664
[TBL] [Abstract][Full Text] [Related]
20. Current concepts in oligometastatic prostate cancer: Is there a role for radical prostatectomy?
Marenco J; Sooriakumaran P
Arch Esp Urol; 2019 Mar; 72(2):174-181. PubMed ID: 30855019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
